Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triple therapy versus conventional therapy for induction treatment of lupus nephritis
2009-017273-38Phase 3Terminated
- Sponsor
- Manuel Praga Terente
- Start
- Jul 2010
- Modality
- Small Molecules, Peptides, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of prednisone, mycophenolic acid and cyclosporine in lupus nephritis (LN) and systemic lupus erythematosus (SLE) (2 arms), sponsored by Manuel Praga Terente. Primary endpoint: Complete remission. Started Jul 2010; status: terminated.
02
Drugs
prednisonemycophenolic acidcyclosporine
03
Conditions
lupus nephritis (LN)systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on 2009-017273-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017273-38.